We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Decellularized Prostate for Cancer Studies

    Abstract

    Regenerative medicine researchers are interested in extracellular matrix (ECM) investigations around fabricating scaffolds that mimic the...

    Mozafar Khazaei, Mohammad Rasool Khazaei, ... Leila Rezakhania in Cell and Tissue Biology
    Article 03 June 2024
  2. Recent advances in flavonoid compounds for the treatment of prostate cancer

    Prostate cancer is a malignant epithelial tumor of the prostate gland and is the most common malignant tumor of the male genitourinary system....

    Wenxuan Fang, Junfang Du, ... Xueni Wang in Molecular Biology Reports
    Article 11 May 2024
  3. Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth

    Sphingosine kinases (SphK), including SphK1 and SphK2, are important enzymes promoting progression of prostate cancer. SKI-178 is a novel and highly...

    Lu **, ** Zhu, ... Wei Tao in Cell Death & Disease
    Article Open access 21 August 2023
  4. The “Ins and Outs” of Prostate Specific Membrane Antigen (PSMA) as Specific Target in Prostate Cancer Therapy

    Prostate-specific membrane antigen (PSMA)PSMA is expressed in epithelial cells of the prostate gland and is strongly upregulated in prostatic...
    Felipe Eltit, Nicole Robinson, ... S. Larry Goldenberg in Advances in Molecular Pathology
    Chapter 2023
  5. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer

    RNA polymerase mitochondria (POLRMT) is essential for mitochondrial transcription machinery and other mitochondrial functions. Its expression and...

    **aojun Li, Linya Yao, ... Ting Jiang in Cell Death & Disease
    Article Open access 10 October 2023
  6. UBE2N promotes cell viability and glycolysis by promoting Axin1 ubiquitination in prostate cancer cells

    Background

    Ubiquitin-conjugating enzyme E2 N (UBE2N) is recognized in the progression of some cancers; however, little research has been conducted to...

    Bo Yang, Weihua Chen, ... Hua Gong in Biology Direct
    Article Open access 07 May 2024
  7. 8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer

    Heat shock protein family B [small] member 6 (HSPB6), widely found in various muscles, has been recently identified as a tumor suppressor gene....

    Yuankang Feng, Zhenlin Huang, ... Zhankui Jia in Cell Death Discovery
    Article Open access 19 February 2024
  8. Ilicicolin C suppresses the progression of prostate cancer by inhibiting PI3K/AKT/mTOR pathway

    Aberrant activation of the PI3K/AKT pathway is a driving factor in the development of prostate cancer. Therefore, inhibiting the function of the...

    **a Gan, **aowei Luo, ... Xueni Wang in Molecular and Cellular Biochemistry
    Article 27 May 2024
  9. Interaction of pRb and β-Catenin in Cancer and Normal Human Prostate Tissue

    Abstract

    Prostate cancer (PCa) is one of the most common oncological diseases, which passes through two stages in its development: localized PCa and...

    V. M. Ryabov, N. I. Tyapkin, ... B. V. Popov in Cell and Tissue Biology
    Article 03 June 2024
  10. Inhibition of CDKL3 downregulates STAT1 thus suppressing prostate cancer development

    Prostate cancer poses a great threat to men’s health worldwide, yet its treatment is still limited by the unclear understanding of its molecular...

    Qi Jiang, Juan Li, ... Weibing Zhang in Cell Death & Disease
    Article Open access 10 March 2023
  11. A novel circular RNA, circMAML3, promotes tumor progression of prostate cancer by regulating miR-665/MAPK8IP2 axis

    Many studies have now demonstrated that circRNAs are aberrantly expressed in cancer and are involved in the regulation of malignant tumor...

    Zeng Zhenhao, Chen Ru, ... Wang Gongxian in Cell Death Discovery
    Article Open access 14 December 2023
  12. Ferroptosis landscape in prostate cancer from molecular and metabolic perspective

    Prostate cancer is a major disease that threatens men’s health. Its rapid progression, easy metastasis, and late castration resistance have brought...

    Jiaming Liang, Yihao Liao, ... Ning Jiang in Cell Death Discovery
    Article Open access 15 April 2023
  13. Cuproptosis Regulates Microenvironment and Affects Prognosis in Prostate Cancer

    Current immunotherapy for prostate cancer is still in the stage of clinical trials. This delay is thought to be caused by an unclear regulatory...

    Chao Li, Yongqiang **ao, ... Fengchao Yin in Biological Trace Element Research
    Article 08 May 2023
  14. Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer

    Tumor expression of prostate-specific membrane antigen (PSMA) is lost in 15–20% of men with castration-resistant prostate cancer (CRPC), yet the...

    Martin K. Bakht, Yasutaka Yamada, ... Himisha Beltran in Nature Cancer
    Article 10 April 2023
  15. Fluorescent Conjugates Based on Prostate-Specific Membrane Antigen Ligands as an Effective Visualization Tool for Prostate Cancer

    Abstract

    Fluorescent dyes are widely used in histological studies and in intraoperative imaging, including surgical treatment of prostate cancer (PC),...

    Anastasiia A. Uspenskaia, Pavel A. Krasnikov, ... Aleksei E. Machulkin in Biochemistry (Moscow)
    Article 20 July 2023
  16. Bacterial Peptides and Bacteriocins as Novel Treatment for Prostate Cancer

    Prostate cancer is well known as the most diagnostic urinary system tumor in the male population. The most conventional cancer therapy is surgery,...

    Keng Ye, Zun** Ke, ... Jianhong Huang in International Journal of Peptide Research and Therapeutics
    Article 17 July 2023
  17. DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2

    Treatment-induced neuroendocrine prostate cancer (t-NEPC) is a lethal subtype of castration-resistant prostate cancer resistant to androgen receptor...

    Roosa Kaarijärvi, Heidi Kaljunen, ... Kirsi Ketola in Communications Biology
    Article Open access 18 January 2024
  18. B7-H3 specific CAR-T cells exhibit potent activity against prostate cancer

    B7-H3 is an attractive target for immunotherapy because of its high expression across multiple solid tumors, including prostate cancer, and...

    Shibao Li, Miaomiao Zhang, ... Gang Wang in Cell Death Discovery
    Article Open access 06 May 2023
  19. Knockdown of KIF15 suppresses proliferation of prostate cancer cells and induces apoptosis through PI3K/Akt signaling pathway

    Prostate cancer is one of the most common malignancies in men, which has been considered a public health threat. KIF15 is a kind of driver protein,...

    Hai Bi, **aofei Hou, ... Jian Lu in Cell Death Discovery
    Article Open access 01 September 2023
  20. Computational Analysis of Differentially Expressed Circulating MicroRNA and Identification of Key Genes in Prostate Cancer

    Bioinformatics is considered a powerful tool to investigate and deeply analyze large datasets. A significant quantity of data is generated by...

    Anveshika Manoj, Shweta Kumari, ... Mohammad Kaleem Ahmad in Indian Journal of Clinical Biochemistry
    Article 28 May 2024
Did you find what you were looking for? Share feedback.